Medtronic Makes Another Big Play In A-Fib, Purchases Ablation Frontiers
This article was originally published in The Gray Sheet
Executive Summary
Medtronic will add anatomically designed radiofrequency ablation catheters for treatment of atrial fibrillation to its fledgling AF Solutions division through the purchase of privately held Ablation Frontiers
You may also be interested in...
Medtronic Gears Up For FDA Panel With Mixed Results From AF Ablation Trial
Medtronic could face more questions than expected at an FDA advisory panel meeting later this month for the firm’s Phased RF Ablation System for atrial fibrillation due to mixed pivotal trial results released last week.
Medtronic Gears Up For FDA Panel With Mixed Results From AF Ablation Trial
Medtronic could face more questions than expected at an FDA advisory panel meeting later this month for the firm’s Phased RF Ablation System for atrial fibrillation due to mixed pivotal trial results released last week.
Regulatory News In Brief
Two a-fib devices go to panel